Corcept Therapeutics Inc
SWB:HTD

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
SWB:HTD
Watchlist
Price: 51.1 EUR -3.04% Market Closed
Market Cap: 3.5B EUR
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Wall Street
Price Targets

HTD Price Targets Summary
Corcept Therapeutics Inc

Wall Street analysts forecast HTD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HTD is 74.17 EUR with a low forecast of 65.7 EUR and a high forecast of 81.55 EUR.

Lowest
Price Target
65.7 EUR
29% Upside
Average
Price Target
74.17 EUR
45% Upside
Highest
Price Target
81.55 EUR
60% Upside
Corcept Therapeutics Inc Competitors:
Price Targets
OGI
OrganiGram Holdings Inc
77% Upside
PAHC
Phibro Animal Health Corp
16% Downside
688166
BrightGene Bio-Medical Technology Co Ltd
41% Upside
CTLT
Catalent Inc
2% Upside
ZTS
Zoetis Inc
31% Upside
SDZ
Sandoz Group AG
15% Upside
HYL
Hyloris Pharmaceuticals SA
127% Upside

Revenue
Forecast

Revenue Estimate
Corcept Therapeutics Inc

For the last 8 years the compound annual growth rate for Corcept Therapeutics Inc's revenue is 33%. The projected CAGR for the next 4 years is 29%.

33%
Past Growth
29%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Corcept Therapeutics Inc

The compound annual growth rate of Corcept Therapeutics Inc's operating income for the next 4 years is 62%.

N/A
Past Growth
62%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Corcept Therapeutics Inc

The compound annual growth rate of Corcept Therapeutics Inc's net income for the next 4 years is 49%.

N/A
Past Growth
49%
Estimated Growth
Estimates Accuracy
14%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HTD's stock price target?
Price Target
74.17 EUR

According to Wall Street analysts, the average 1-year price target for HTD is 74.17 EUR with a low forecast of 65.7 EUR and a high forecast of 81.55 EUR.

What is Corcept Therapeutics Inc's Revenue forecast?
Projected CAGR
29%

For the last 8 years the compound annual growth rate for Corcept Therapeutics Inc's revenue is 33%. The projected CAGR for the next 4 years is 29%.

What is Corcept Therapeutics Inc's Operating Income forecast?
Projected CAGR
62%

The compound annual growth rate of Corcept Therapeutics Inc's operating income for the next 4 years is 62%.

What is Corcept Therapeutics Inc's Net Income forecast?
Projected CAGR
49%

The compound annual growth rate of Corcept Therapeutics Inc's net income for the next 4 years is 49%.

Back to Top